Basic Information
| LncRNA/CircRNA Name | LOXL1-AS |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thoracic aortic aneurysm |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, etc. |
| Sample | TAA tissues, |
| Expression Pattern | up-regulated |
| Function Description | LOXL1-AS was upregulated in TAA patients than in healthy controls in aortic media specimens. Altered expression levels of LOXL1-AS distinguished TAA patients from healthy controls. LncRNA Giver was also upregulated in TAA patients than in healthy controls in aortic media specimens, and was positively correlated with LOXL1-AS. LOXL1-AS overexpression mediated the upregulation of Giver in human aortic smooth muscle cells (HAOSMC), while Giver overexpression failed to significantly affect LOXL1- AS. LOXL1-AS and Giver overexpression resulted in promoted proliferation and inhibited apoptosis of HAOSMC. Giver silencing played an opposite role and attenuated the effect of LOXL1-AS overexpression. Therefore, LOXL1-AS was upregulated in TAA and regulated proliferation and apoptosis of LOXL1-AS by upregulating Giver. |
| Pubmed ID | 31471532 |
| Year | 2019 |
| Title | LncRNA LOXL1-AS is upregulated in thoracic aortic aneurysm and regulated proliferation and apoptosis of aortic smooth muscle cells |
External Links
| Links for LOXL1-AS | GenBank HGNC NONCODE |
| Links for thoracic aortic aneurysm | OMIM COSMIC |